Advanced Search

Study Preview



Study Title and Description

Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.



Key Questions Addressed
2 Key Question 2. In adult women without preexisting breast cancer, what is the effectiveness and comparative effectiveness of medications to reduce risk for primary breast cancer on improvement in short- and long-term health outcomes, including invasive breast cancer, noninvasive breast cancer (including ductal carcinoma in situ), breast cancer mortality, all-cause mortality, and other beneficial outcomes (such as reduced fractures caused by certain medications and improved quality of life)? Key Question 2a. Does the effectiveness of risk-reducing medications vary by timing of initiation or duration of use? Key Question 2b. Does the effectiveness of risk-reducing medications persist beyond discontinuation of use?
  • Comments Comments (
    0
    ) |
3 Key Question 3. What are the harms of using medications to reduce risk for primary breast cancer? Key Question 3a. Do harms of risk-reducing medications vary by timing of initiation and/or duration of use? Key Question 3b. Do harms of risk-reducing medications persist beyond discontinuation of use?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.
Author Grady D., Ettinger B., Moscarelli E., Plouffe L., Sarkar S., Ciaccia A., Cummings S.
Country University of California-San Francisco, 1634 Divisadero Street, Suite 600, San Francisco, CA 94115, USA. dgrady@itsa.ucsf.edu
Year 2004
Numbers Pubmed ID: 15458908

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.